Related references
Note: Only part of the references are listed.Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
Bruce C. Campbell et al.
LANCET (2019)
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
H. Ma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
G. Thomalla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
B. C. V. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
G. W. Albers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
R. G. Nogueira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke)
Ruediger von Kummer et al.
STROKE (2016)
The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion
Hayley M. Wheeler et al.
INTERNATIONAL JOURNAL OF STROKE (2015)
Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial
Gregory W. Albers et al.
LANCET NEUROLOGY (2015)
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
Jeffrey L. Saver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
B. C. V. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson et al.
LANCET (2014)
A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
Chelsea S. Kidwell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke
Mark Parsons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Systematic Review of Perfusion Imaging With Computed Tomography and Magnetic Resonance in Acute Ischemic Stroke: Heterogeneity of Acquisition and Postprocessing Parameters A Translational Medicine Research Collaboration Multicentre Acute Stroke Imaging Study
Krishna A. Dani et al.
STROKE (2012)
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
Werner Hacke et al.
LANCET NEUROLOGY (2009)
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial
Stephen M. Davis et al.
LANCET NEUROLOGY (2008)
Dose escalation of desmoteplase for acute ischemic stroke (DEDAS) - Evidence of safety and efficacy 3 to 9 hours after stroke onset
AJ Furlan et al.
STROKE (2006)
The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase
W Hacke et al.
STROKE (2005)
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility
PA Barber et al.
NEUROLOGY (2001)
Share Paper
